Blood components are the products derived from platelet-rich plasma or whole blood. Blood components like platelets, plasma, red blood cells, and white blood cells are derived from the blood by phlebotomy or hemapheresis through differential centrifugation. These blood components are isolated from whole blood in hospital laboratories and blood centers and are administered to patients suffering from several diseases through transfusion. The whole blood is usually collected and separated into major components before transfusion. Nevertheless, automated collections are becoming increasingly popular nowadays, and only blood components that are needed for transfusion are collected.
MARKET SCOPE
The "Global Blood Preparation Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Blood preparation market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Blood preparation market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product type, the global Blood preparation market is segmented into whole blood, blood derivatives, and blood components. Whole blood is segmented into rbc, plasma, platelets. Blood components is segmented into whole blood components, packed red cells, leukocyte reduced red blood cells, frozen plasma, platelet concentrate, cryoprecipitate.
- On the basis of application, the market is segmented into thrombocytosis, pulmonary embolism, renal impairment, angina blood vessel complications, others
- On the basis of end use, the market is segmented into hospitals, clinics, diagnostic centers, research labs, blood banks, pharmaceuticals, others.
MARKET DYNAMICS
Drivers:
- Rise in the demand for blood transfusion.
- Introduction of novel technologies along with the increasing usage of plasma in the pharmaceutical industry.
- Technological advancements.
Restraints:
- The risk of transmission of diseases is the major restraining factor for this market.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Blood preparation market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Blood preparation market in these regions.
IMPACT OF COVID-19 ON BLOOD PREPARATION MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. Coronavirus strains have been the cause of countless deaths and infections in the past. Outbreaks have been progressively more regular over the past few decades, and there is a critical need for accurate diagnostic procedures for the coronavirus. The plasma therapy, known as convalescent plasma treatment, needs blood plasma donations from people who have recuperated from Covid-19. This plasma is administered to Covid-19 patients who could not produce enough antibodies against the virus, so the plasma is required and will boost the market growth
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Blood preparation market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Blood preparation market in these regions.
IMPACT OF COVID-19 ON BLOOD PREPARATION MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. Coronavirus strains have been the cause of countless deaths and infections in the past. Outbreaks have been progressively more regular over the past few decades, and there is a critical need for accurate diagnostic procedures for the coronavirus. The plasma therapy, known as convalescent plasma treatment, needs blood plasma donations from people who have recuperated from Covid-19. This plasma is administered to Covid-19 patients who could not produce enough antibodies against the virus, so the plasma is required and will boost the market growth
MARKET PLAYERS
The report covers key developments in the Blood preparation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Blood preparation market are anticipated to lucrative growth opportunities in the future with the rising demand for Blood preparation in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Blood preparation market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- AstraZeneca PLC
- Sanofi S.A
- LEO Pharma A/S
- Bristol-Myers Squibb Company
- Baxter International, Inc
- Pfizer, Inc.
- Portola Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Shandong East Chemical Industry Co
- Celgene Corporation
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Blood Preparation Market - By Product Type
1.3.2 Blood Preparation Market - By Application
1.3.3 Blood Preparation Market - By End Use
1.3.4 Blood Preparation Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BLOOD PREPARATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BLOOD PREPARATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BLOOD PREPARATION MARKET - GLOBAL MARKET ANALYSIS
6.1. BLOOD PREPARATION - GLOBAL MARKET OVERVIEW
6.2. BLOOD PREPARATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. BLOOD PREPARATION MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. WHOLE BLOOD
7.3.1. Overview
7.3.2. Whole Blood Market Forecast and Analysis
7.3.3. RBC Market
7.3.3.1. Overview
7.3.3.2. RBC Market Forecast and Analysis
7.3.4. Plasma Market
7.3.4.1. Overview
7.3.4.2. Plasma Market Forecast and Analysis
7.3.5. Platelets Market
7.3.5.1. Overview
7.3.5.2. Platelets Market Forecast and Analysis
7.4. BLOOD COMPONENTS
7.4.1. Overview
7.4.2. Blood Components Market Forecast and Analysis
7.4.3. Whole Blood Components Market
7.4.3.1. Overview
7.4.3.2. Whole Blood Components Market Forecast and Analysis
7.4.4. Packed Red Cells Market
7.4.4.1. Overview
7.4.4.2. Packed Red Cells Market Forecast and Analysis
7.4.5. Leukocyte Reduced Red Blood Cells Market
7.4.5.1. Overview
7.4.5.2. Leukocyte Reduced Red Blood Cells Market Forecast and Analysis
7.4.6. Frozen Plasma Market
7.4.6.1. Overview
7.4.6.2. Frozen Plasma Market Forecast and Analysis
7.4.7. Platelet Concentrate Market
7.4.7.1. Overview
7.4.7.2. Platelet Concentrate Market Forecast and Analysis
7.4.8. Cryoprecipitate Market
7.4.8.1. Overview
7.4.8.2. Cryoprecipitate Market Forecast and Analysis
7.5. BLOOD DERIVATIVES
7.5.1. Overview
7.5.2. Blood Derivatives Market Forecast and Analysis
8. BLOOD PREPARATION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. THROMBOCYTOSIS
8.3.1. Overview
8.3.2. Thrombocytosis Market Forecast and Analysis
8.4. PULMONARY EMBOLISM
8.4.1. Overview
8.4.2. Pulmonary Embolism Market Forecast and Analysis
8.5. RENAL IMPAIRMENT
8.5.1. Overview
8.5.2. Renal Impairment Market Forecast and Analysis
8.6. ANGINA BLOOD VESSEL COMPLICATIONS
8.6.1. Overview
8.6.2. Angina Blood Vessel Complications Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. BLOOD PREPARATION MARKET - REVENUE AND FORECASTS TO 2028 - END USE
9.1. OVERVIEW
9.2. END USE MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. DIAGNOSTIC CENTERS
9.5.1. Overview
9.5.2. Diagnostic Centers Market Forecast and Analysis
9.6. RESEARCH LABS
9.6.1. Overview
9.6.2. Research Labs Market Forecast and Analysis
9.7. BLOOD BANKS
9.7.1. Overview
9.7.2. Blood Banks Market Forecast and Analysis
9.8. PHARMACEUTICALS
9.8.1. Overview
9.8.2. Pharmaceuticals Market Forecast and Analysis
9.9. OTHERS
9.9.1. Overview
9.9.2. Others Market Forecast and Analysis
10. BLOOD PREPARATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Blood Preparation Market Overview
10.1.2 North America Blood Preparation Market Forecasts and Analysis
10.1.3 North America Blood Preparation Market Forecasts and Analysis - By Product Type
10.1.4 North America Blood Preparation Market Forecasts and Analysis - By Application
10.1.5 North America Blood Preparation Market Forecasts and Analysis - By End Use
10.1.6 North America Blood Preparation Market Forecasts and Analysis - By Countries
10.1.6.1 United States Blood Preparation Market
10.1.6.1.1 United States Blood Preparation Market by Product Type
10.1.6.1.2 United States Blood Preparation Market by Application
10.1.6.1.3 United States Blood Preparation Market by End Use
10.1.6.2 Canada Blood Preparation Market
10.1.6.2.1 Canada Blood Preparation Market by Product Type
10.1.6.2.2 Canada Blood Preparation Market by Application
10.1.6.2.3 Canada Blood Preparation Market by End Use
10.1.6.3 Mexico Blood Preparation Market
10.1.6.3.1 Mexico Blood Preparation Market by Product Type
10.1.6.3.2 Mexico Blood Preparation Market by Application
10.1.6.3.3 Mexico Blood Preparation Market by End Use
10.2. EUROPE
10.2.1 Europe Blood Preparation Market Overview
10.2.2 Europe Blood Preparation Market Forecasts and Analysis
10.2.3 Europe Blood Preparation Market Forecasts and Analysis - By Product Type
10.2.4 Europe Blood Preparation Market Forecasts and Analysis - By Application
10.2.5 Europe Blood Preparation Market Forecasts and Analysis - By End Use
10.2.6 Europe Blood Preparation Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Blood Preparation Market
10.2.6.1.1 Germany Blood Preparation Market by Product Type
10.2.6.1.2 Germany Blood Preparation Market by Application
10.2.6.1.3 Germany Blood Preparation Market by End Use
10.2.6.2 France Blood Preparation Market
10.2.6.2.1 France Blood Preparation Market by Product Type
10.2.6.2.2 France Blood Preparation Market by Application
10.2.6.2.3 France Blood Preparation Market by End Use
10.2.6.3 Italy Blood Preparation Market
10.2.6.3.1 Italy Blood Preparation Market by Product Type
10.2.6.3.2 Italy Blood Preparation Market by Application
10.2.6.3.3 Italy Blood Preparation Market by End Use
10.2.6.4 Spain Blood Preparation Market
10.2.6.4.1 Spain Blood Preparation Market by Product Type
10.2.6.4.2 Spain Blood Preparation Market by Application
10.2.6.4.3 Spain Blood Preparation Market by End Use
10.2.6.5 United Kingdom Blood Preparation Market
10.2.6.5.1 United Kingdom Blood Preparation Market by Product Type
10.2.6.5.2 United Kingdom Blood Preparation Market by Application
10.2.6.5.3 United Kingdom Blood Preparation Market by End Use
10.2.6.6 Rest of Europe Blood Preparation Market
10.2.6.6.1 Rest of Europe Blood Preparation Market by Product Type
10.2.6.6.2 Rest of Europe Blood Preparation Market by Application
10.2.6.6.3 Rest of Europe Blood Preparation Market by End Use
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Blood Preparation Market Overview
10.3.2 Asia-Pacific Blood Preparation Market Forecasts and Analysis
10.3.3 Asia-Pacific Blood Preparation Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Blood Preparation Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Blood Preparation Market Forecasts and Analysis - By End Use
10.3.6 Asia-Pacific Blood Preparation Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Blood Preparation Market
10.3.6.1.1 Australia Blood Preparation Market by Product Type
10.3.6.1.2 Australia Blood Preparation Market by Application
10.3.6.1.3 Australia Blood Preparation Market by End Use
10.3.6.2 China Blood Preparation Market
10.3.6.2.1 China Blood Preparation Market by Product Type
10.3.6.2.2 China Blood Preparation Market by Application
10.3.6.2.3 China Blood Preparation Market by End Use
10.3.6.3 India Blood Preparation Market
10.3.6.3.1 India Blood Preparation Market by Product Type
10.3.6.3.2 India Blood Preparation Market by Application
10.3.6.3.3 India Blood Preparation Market by End Use
10.3.6.4 Japan Blood Preparation Market
10.3.6.4.1 Japan Blood Preparation Market by Product Type
10.3.6.4.2 Japan Blood Preparation Market by Application
10.3.6.4.3 Japan Blood Preparation Market by End Use
10.3.6.5 South Korea Blood Preparation Market
10.3.6.5.1 South Korea Blood Preparation Market by Product Type
10.3.6.5.2 South Korea Blood Preparation Market by Application
10.3.6.5.3 South Korea Blood Preparation Market by End Use
10.3.6.6 Rest of Asia-Pacific Blood Preparation Market
10.3.6.6.1 Rest of Asia-Pacific Blood Preparation Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Blood Preparation Market by Application
10.3.6.6.3 Rest of Asia-Pacific Blood Preparation Market by End Use
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Blood Preparation Market Overview
10.4.2 Middle East and Africa Blood Preparation Market Forecasts and Analysis
10.4.3 Middle East and Africa Blood Preparation Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Blood Preparation Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Blood Preparation Market Forecasts and Analysis - By End Use
10.4.6 Middle East and Africa Blood Preparation Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Blood Preparation Market
10.4.6.1.1 South Africa Blood Preparation Market by Product Type
10.4.6.1.2 South Africa Blood Preparation Market by Application
10.4.6.1.3 South Africa Blood Preparation Market by End Use
10.4.6.2 Saudi Arabia Blood Preparation Market
10.4.6.2.1 Saudi Arabia Blood Preparation Market by Product Type
10.4.6.2.2 Saudi Arabia Blood Preparation Market by Application
10.4.6.2.3 Saudi Arabia Blood Preparation Market by End Use
10.4.6.3 U.A.E Blood Preparation Market
10.4.6.3.1 U.A.E Blood Preparation Market by Product Type
10.4.6.3.2 U.A.E Blood Preparation Market by Application
10.4.6.3.3 U.A.E Blood Preparation Market by End Use
10.4.6.4 Rest of Middle East and Africa Blood Preparation Market
10.4.6.4.1 Rest of Middle East and Africa Blood Preparation Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Blood Preparation Market by Application
10.4.6.4.3 Rest of Middle East and Africa Blood Preparation Market by End Use
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Blood Preparation Market Overview
10.5.2 South and Central America Blood Preparation Market Forecasts and Analysis
10.5.3 South and Central America Blood Preparation Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Blood Preparation Market Forecasts and Analysis - By Application
10.5.5 South and Central America Blood Preparation Market Forecasts and Analysis - By End Use
10.5.6 South and Central America Blood Preparation Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Blood Preparation Market
10.5.6.1.1 Brazil Blood Preparation Market by Product Type
10.5.6.1.2 Brazil Blood Preparation Market by Application
10.5.6.1.3 Brazil Blood Preparation Market by End Use
10.5.6.2 Argentina Blood Preparation Market
10.5.6.2.1 Argentina Blood Preparation Market by Product Type
10.5.6.2.2 Argentina Blood Preparation Market by Application
10.5.6.2.3 Argentina Blood Preparation Market by End Use
10.5.6.3 Rest of South and Central America Blood Preparation Market
10.5.6.3.1 Rest of South and Central America Blood Preparation Market by Product Type
10.5.6.3.2 Rest of South and Central America Blood Preparation Market by Application
10.5.6.3.3 Rest of South and Central America Blood Preparation Market by End Use
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BLOOD PREPARATION MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. BLOOD PREPARATION MARKET, KEY COMPANY PROFILES
13.1. ASTRAZENECA PLC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. SANOFI S.A
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. LEO PHARMA A/S
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BRISTOL MYERS SQUIBB COMPANY
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BAXTER INTERNATIONAL, INC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PFIZER, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PORTOLA PHARMACEUTICALS, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. GLAXOSMITHKLINE PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SHANDONG EAST CHEMICAL INDUSTRY CO.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. CELGENE CORPORATION
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. AstraZeneca PLC
2. Sanofi S.A
3. LEO Pharma A/S
4. Bristol-Myers Squibb Company
5. Baxter International, Inc
6. Pfizer, Inc.
7. Portola Pharmaceuticals, Inc.
8. GlaxoSmithKline PLC
9. Shandong East Chemical Industry Co
10. Celgene Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Blood Preparation Market
Apr 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2024
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)